{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:12:51Z","timestamp":1792087971505,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A21623"],"award-info":[{"award-number":["A21623"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000351","name":"British Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009360","name":"King\u2019s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004941","name":"Guy's and St Thomas' NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.xcrm.2021.100457","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T10:52:49Z","timestamp":1640083969000},"page":"100457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Synergistic T\u00a0cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors"],"prefix":"10.1016","volume":"2","author":[{"given":"Tamara","family":"Muliaditan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynsey M.","family":"Whilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7735-3988","authenticated-orcid":false,"given":"Benjamin","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Y.","family":"Achkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahima","family":"Kausar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6561-6311","authenticated-orcid":false,"given":"Natasha","family":"Bechman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Appitha","family":"Arulappu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5263-6674","authenticated-orcid":false,"given":"Katie R.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Obajdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiana","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Antoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Larcombe-Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Buus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3434-201X","authenticated-orcid":false,"given":"Anita","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-6986","authenticated-orcid":false,"given":"David M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2525-3114","authenticated-orcid":false,"given":"Anna","family":"Schurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8275-8488","authenticated-orcid":false,"given":"John","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2021.100457_bib1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0006-291X(87)90502-X","article-title":"Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions","volume":"149","author":"Kuwana","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2021.100457_bib2","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.4049\/jimmunol.161.6.2791","article-title":"Chimeric receptors providing both primary and costimulatory signaling in T\u00a0cells from a single gene product","volume":"161","author":"Finney","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4049\/jimmunol.172.1.104","article-title":"Activation of resting human primary T\u00a0cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain","volume":"172","author":"Finney","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt0102-70","article-title":"Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta \/CD28 receptor","volume":"20","author":"Maher","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2021.100457_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.leu.2403302","article-title":"Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia","volume":"18","author":"Imai","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2021.100457_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14712598.2020.1738378","article-title":"Prospects and challenges for use of CAR T\u00a0cell therapies in solid tumors","volume":"20","author":"Ramakrishna","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.xcrm.2021.100457_bib7","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ymthe.2005.04.016","article-title":"A chimeric T\u00a0cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T\u00a0cells","volume":"12","author":"Pule","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2021.100457_bib8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1089\/hum.2007.028","article-title":"Optimizing adoptive polyclonal T\u00a0cell immunotherapy of lymphomas, using a chimeric T\u00a0cell receptor possessing CD28 and CD137 costimulatory domains","volume":"18","author":"Wang","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2021.100457_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/mt.2009.210","article-title":"Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase\/AKT\/Bcl-XL activation and CD8+ T\u00a0cell-mediated tumor eradication","volume":"18","author":"Zhong","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2021.100457_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/hum.2009.122","article-title":"4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T\u00a0cells against B-cell malignancies","volume":"21","author":"Tammana","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2021.100457_bib11","doi-asserted-by":"crossref","first-page":"e0144787","DOI":"10.1371\/journal.pone.0144787","article-title":"Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors","volume":"10","author":"Karlsson","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100457_bib12","doi-asserted-by":"crossref","first-page":"96976","DOI":"10.1172\/jci.insight.96976","article-title":"Enhancing CAR T\u00a0cell persistence through ICOS and 4-1BB costimulation","volume":"3","author":"Guedan","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2021.100457_bib13","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.180.7.4901","article-title":"Retargeting of human T\u00a0cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor","volume":"180","author":"Wilkie","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/mt.2009.83","article-title":"Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T\u00a0cells and increased antileukemic efficacy in\u00a0vivo","volume":"17","author":"Milone","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2021.100457_bib15","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0813101106","article-title":"Control of large, established tumor xenografts with genetically retargeted human T\u00a0cells containing CD28 and CD137 domains","volume":"106","author":"Carpenito","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100457_bib16","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/mt.2013.192","article-title":"Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 \u201csuper-stimulation\u201d","volume":"21","author":"Hombach","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2021.100457_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/hum.2013.209","article-title":"A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancer","volume":"25","author":"Abate-Daga","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2021.100457_bib18","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1116::AID-IMMU1116>3.0.CO;2-A","article-title":"Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway","volume":"28","author":"Melero","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib19","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.4049\/jimmunol.168.10.4897","article-title":"4-1BB ligand-mediated costimulation of human T\u00a0cells induces CD4 and CD8 T\u00a0cell expansion, cytokine production, and the development of cytolytic effector function","volume":"168","author":"Wen","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt0202-143","article-title":"Ex\u00a0vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB","volume":"20","author":"Maus","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2021.100457_bib21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","article-title":"Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells","volume":"28","author":"Zhao","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2021.100457_bib22","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1158\/1078-0432.CCR-18-2559","article-title":"Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells","volume":"25","author":"Drent","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2021.100457_bib23","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/eji.1830261006","article-title":"Antigen-specific targeting of CD28-mediated T\u00a0cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors","volume":"26","author":"Alvarez-Vallina","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10875-012-9689-9","article-title":"Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling","volume":"32","author":"Wilkie","year":"2012","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nbt.2459","article-title":"Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T\u00a0cells","volume":"31","author":"Kloss","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2021.100457_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.1154370","article-title":"Discovery of a cytokine and its receptor by functional screening of the extracellular proteome","volume":"320","author":"Lin","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100457_bib27","doi-asserted-by":"crossref","first-page":"25538","DOI":"10.1074\/jbc.M110.127951","article-title":"Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4","volume":"285","author":"Wilkie","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2021.100457_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T\u00a0cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib29","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","article-title":"Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T\u00a0cells exposed to persistent antigen","volume":"21","author":"Vardhana","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib30","doi-asserted-by":"crossref","first-page":"121322","DOI":"10.1172\/jci.insight.121322","article-title":"4-1BB enhancement of CAR T function requires NF-\u03baB and TRAFs","volume":"3","author":"Li","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2021.100457_bib31","doi-asserted-by":"crossref","first-page":"E2828","DOI":"10.3390\/cancers12102828","article-title":"Senescent Tumor CD8+ T Cells: Mechanisms of Induction and Challenges to Immunotherapy","volume":"12","author":"Liu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2021.100457_bib32","doi-asserted-by":"crossref","first-page":"e1049","DOI":"10.1002\/cti2.1049","article-title":"Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations","volume":"8","author":"Weinkove","year":"2019","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/2326-6066.CIR-14-0200","article-title":"Functional Tuning of CARs Reveals Signaling Threshold above Which CD8+ CTL Antitumor Potency Is Attenuated due to Cell Fas-FasL-Dependent AICD","volume":"3","author":"K\u00fcnkele","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2021.100457_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI0214941","article-title":"Activation and inhibition of lymphocytes by costimulation","volume":"109","author":"Frauwirth","year":"2002","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2021.100457_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cell.2017.08.018","article-title":"Mitochondrial Priming by CD28","volume":"171","author":"Klein Geltink","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2021.100457_bib36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","article-title":"Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2021.100457_bib37","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4049\/jimmunol.1901399","article-title":"Cutting Edge: Activation-Induced Iron Flux Controls CD4\u00a0T Cell Proliferation by Promoting Proper IL-2R Signaling and Mitochondrial Function","volume":"204","author":"Yarosz","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1074-7613(02)00323-0","article-title":"The CD28 signaling pathway regulates glucose metabolism","volume":"16","author":"Frauwirth","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2021.100457_bib39","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","article-title":"Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8\u00a0T Cells in the Same Host","volume":"16","author":"Schurich","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2021.100457_bib40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2021.100457_bib41","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","article-title":"The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research","volume":"15","author":"Cheever","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2021.100457_bib42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2119\/molmed.2011.00493","article-title":"Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T\u00a0cells","volume":"18","author":"Davies","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.xcrm.2021.100457_bib43","doi-asserted-by":"crossref","first-page":"100227","DOI":"10.1016\/j.xcrm.2021.100227","article-title":"Hypoxia-sensing CAR T\u00a0cells provide safety and efficacy in treating solid tumors","volume":"2","author":"Kosti","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2021.100457_bib44","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.4049\/jimmunol.1301523","article-title":"Preclinical in\u00a0vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T\u00a0cells: identifying a window of therapeutic opportunity?","volume":"191","author":"van der Stegen","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrd4597","article-title":"The pharmacology of second-generation chimeric antigen receptors","volume":"14","author":"van der Stegen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2021.100457_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ymthe.2016.10.012","article-title":"Targeting of Aberrant \u03b1v\u03b26 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells","volume":"25","author":"Whilding","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2021.100457_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8\u00a0T Cell Exhaustion During Chronic Viral Infection and Cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib48","doi-asserted-by":"crossref","first-page":"eaat6753","DOI":"10.1126\/scisignal.aat6753","article-title":"Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function","volume":"11","author":"Salter","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2021.100457_bib49","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1073\/pnas.0502393102","article-title":"HIV-1-specific IFN-gamma\/IL-2-secreting CD8 T\u00a0cells support CD4-independent proliferation of HIV-1-specific CD8 T\u00a0cells","volume":"102","author":"Zimmerli","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100457_bib50","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.4049\/jimmunol.0902580","article-title":"Dynamic regulation of CD8 T\u00a0cell tolerance induction by liver sinusoidal endothelial cells","volume":"184","author":"Schurich","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib51","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ni.2079","article-title":"Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T\u00a0cells","volume":"12","author":"Feau","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib52","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm.4478","article-title":"A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects","volume":"24","author":"Kagoya","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100457_bib53","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.20171068","article-title":"4-1BB costimulation induces T\u00a0cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses","volume":"215","author":"Menk","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2021.100457_bib54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2021.100457_bib55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nm.4275","article-title":"Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T\u00a0cells in chronic hepatitis B","volume":"23","author":"Fisicaro","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100457_bib56","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.molimm.2007.09.010","article-title":"Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation","volume":"45","author":"Lo","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.xcrm.2021.100457_bib57","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nm.2129","article-title":"Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma","volume":"16","author":"Lamprecht","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100457_bib58","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/CJI.0b013e3181ac6138","article-title":"Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor","volume":"32","author":"Kochenderfer","year":"2009","journal-title":"J. Immunother."},{"key":"10.1016\/j.xcrm.2021.100457_bib59","doi-asserted-by":"crossref","first-page":"E674","DOI":"10.3390\/cancers11050674","article-title":"CAR T-Cells Targeting the Integrin \u03b1v\u03b26 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies","volume":"11","author":"Whilding","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2021.100457_bib60","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/bioinformatics\/bts188","article-title":"NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data","volume":"28","author":"Waggott","year":"2012","journal-title":"Bioinformatics"},{"issue":"W1","key":"10.1016\/j.xcrm.2021.100457_bib61","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2021.100457_bib62","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121003256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121003256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:49:56Z","timestamp":1762987796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379121003256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2666379121003256"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100457","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic T\u00a0cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100457"}}